Table 2.
Comparison of outcomes between the intervention and nonintervention groups at the end of the study
| Variable | Intervention group (n = 303) | Nonintervention group (n = 278) | p-Value | ||
|---|---|---|---|---|---|
| n | % | n | % | ||
| Adherence | |||||
| Self-reported | 193 | 63.7 | 177 | 63.7 | 1.00 |
| Detectable level in blood | 85/105 | 81.0 | 64/86 | 74.4 | 0.28 |
| Optimal level in blood | 50/105 | 47.6 | 43/86 | 50.0 | 0.74 |
| AED levels in blood: mean level (SD) | |||||
| Phenobarbital | 63 | 13.1 (11.9) | 53 | 11.3 (10.8) | 0.35 |
| Phenytoin | 46 | 2.1 (2.2) | 41 | 2.4 (3.8) | 0.70 |
| Carbamazepine | 34 | 3.3 (4.3) | 48 | 3.7 (3.9) | 0.66 |
| Seizures | |||||
| Less frequent seizures | 243 | 80.2 | 208 | 74.8 | 0.12 |
| Seizure frequency (last 3 months) | |||||
| None | 154 | 50.8 | 130 | 46.8 | |
| 1–3 | 89 | 29.4 | 78 | 28.1 | |
| 4–6 | 26 | 8.6 | 26 | 9.4 | |
| >6 | 34 | 11.2 | 44 | 15.8 | 0.40 |
| KEBAS | n | Mean (SD) | N | Mean (SD) | p-Value |
|---|---|---|---|---|---|
| Beliefs about causes of epilepsy | 303 | 7.4 (2.6) | 278 | 7.0 (2.7) | 0.04 |
| Beliefs about biomedical treatment | 303 | 15.1 (15.1) | 278 | 15.0 (1.9) | 0.57 |
| Beliefs about cultural treatment | 303 | 12.8 (4.1) | 278 | 11.6 (4.3) | <0.001 |
| Beliefs about risks of epilepsy | 303 | 7.3 (1.3) | 278 | 7.4 (1.4) | 0.27 |
| Stereotypes about epilepsy | 303 | 11.0 (3.8) | 278 | 10.0 (3.9) | <0.001 |
If all the data were not available, both the numerator and denominators are provided. % column records percentage of those observed with the characteristic under consideration except for the items of KEBAS and levels of AEDs in blood where we have the mean (standard deviation) of the scores.